Covadonga Pañeda
Operationeel Directeur bij ALTAMIRA THERAPEUTICS LTD.
Actieve functies van Covadonga Pañeda
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ALTAMIRA THERAPEUTICS LTD. | Operationeel Directeur | 01-01-2023 | - |
Corporate Officer/Principal | - | 01-01-2023 |
Loopbaan van Covadonga Pañeda
Eerdere bekende functies van Covadonga Pañeda
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Corporate Officer/Principal | 01-10-2020 | 01-04-2022 |
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Hoofd Techniek/Wetenschap/O&O | 01-03-2011 | 01-06-2018 |
Opleiding van Covadonga Pañeda
Universidad Autónoma de Madrid | Doctorate Degree |
Statistieken
Internationaal
Spanje | 3 |
Bermuda | 2 |
Frankrijk | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ALTAMIRA THERAPEUTICS LTD. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Health Technology |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Finance |
- Beurs
- Insiders
- Covadonga Pañeda
- Ervaring